Tipping Point Biosciences

About Tipping Point Biosciences

Tipping Point Biosciences is a biotechnology company focused on developing therapies that target diseases driven by chromatin dysfunction. Their work emphasizes novel approaches to drugging chromatin networks, including challenging targets such as pediatric brain tumors like diffuse midline glioma. The team comprises researchers and clinicians from UCSF, Stanford, and other leading institutions, collaborating to advance precision oncology with reduced toxicity and resistance. The company is based in the San Francisco Bay Area and engages in early discovery and translational research to address high unmet medical needs.